NOVAVAX INC (NVAX.MX)
Makes vaccines for COVID-19 and malaria using protein-based technology.
129.02-0.02%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+4.0%
The outlook
NVAX is trading near its 52-week low, well below both its 50- and 200-day moving averages. The stock sits in the lower portion of its annual range, suggesting a prolonged downtrend. Analyst coverage appears thin based on the data provided.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range16% of the way from its 52-week low to high
Market cap
—
52-wk high
204.88
52-wk low
115.00
50-day avg
159.71
200-day avg
150.67
Trailing P/E
—